Repository logo
 

Hippocampal and insula volume in mild cognitive impairment with Lewy bodies.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Firbank, Michael J 
Durcan, Rory 
O'Brien, John T 
Allan, Louise M 
Barker, Sally 

Abstract

INTRODUCTION: Diagnostic criteria for prodromal dementia with Lewy bodies have recently been published. These include the use of imaging biomarkers to distinguish mild cognitive impairment with Lewy bodies (MCI-LB) from MCI due to other causes. Two potential biomarkers listed, though not formally included in the diagnostic criteria, due to insufficient evidence, are relatively preserved hippocampi, and atrophy of the insula cortex on structural brain imaging. METHODS: In this report, we sought to investigate these imaging biomarkers in 105 research subjects, including well characterised groups of patients with MCI-LB (n = 38), MCI with no core features of Lewy body disease (MCI-AD; n = 36) and healthy controls (N = 31). Hippocampal and insula volumes were determined from T1 weighted structural MRI scans, using grey matter segmentation performed with SPM software. RESULTS: Adjusting for age, sex and intracranial volume, there were no differences in hippocampal or insula volume between MCI-AD and MCI-LB, although in both conditions volumes were significantly reduced relative to controls. CONCLUSION: Our results do not support the use of either hippocampal or insula volume to identify prodromal dementia with Lewy bodies.

Description

Keywords

Biomarker, Hippocampus, Insula, Lewy body, MCI, MRI, Aged, Aged, 80 and over, Cognitive Dysfunction, Female, Hippocampus, Humans, Insular Cortex, Lewy Body Disease, Magnetic Resonance Imaging, Male, Middle Aged, Prodromal Symptoms

Journal Title

Parkinsonism Relat Disord

Conference Name

Journal ISSN

1353-8020
1873-5126

Volume Title

86

Publisher

Elsevier BV
Sponsorship
This work was supported by Alzheimer’s Research UK (AJT, Grant Number ARUK-PG3026-13) and the NIHR Newcastle Biomedical Research Centre. GE Healthcare provided funding for FP-CIT imaging for this investigator-led study. JOB is supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Centre for Parkinson’s Plus.